Glaxo CEO Sees 'Tremendous' Growth Opportunity After Tesaro Deal

The video features a discussion with GSK's CEO about the company's recent strategic moves, including the acquisition of Tesoro and partnerships with 23andMe and Pfizer. The focus is on reshaping GSK's portfolio to enhance shareholder returns and patient impact. The CEO highlights the importance of disciplined capital allocation and the potential of Tesoro's assets in treating ovarian cancer. The video also covers GSK's financial strategy, including debt management and future investment plans.

What were some of the key deals GSK announced in December?

How does GSK's joint venture with Pfizer create value for shareholders?

What is GSK's approach to managing debt in relation to future deals?